Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

Corporate Breaking News

Home : Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

Nov 02 2010	Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters
PHILADELPHIA and LONDON, Nov. 3, 2010 /PRNewswire/ -- Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR


Source:http://www.prnewswire.com/news-releases/asia-pacific-pharma-companies-turning-to-high-risk-high-reward-drug-development-according-to-new-report-from-thomson-reuters-106583858.html

Related News
» Verizon Business Earns Telemark's 'World-Class' Ranking Among Information Communications Technology Providers » KongZhong Schedules Conference Call for 2010 Third Quarter Earnings